HK1043310B - 含有谷胱甘肽类似物的治疗用组合物 - Google Patents

含有谷胱甘肽类似物的治疗用组合物 Download PDF

Info

Publication number
HK1043310B
HK1043310B HK02104871.4A HK02104871A HK1043310B HK 1043310 B HK1043310 B HK 1043310B HK 02104871 A HK02104871 A HK 02104871A HK 1043310 B HK1043310 B HK 1043310B
Authority
HK
Hong Kong
Prior art keywords
lipid
parts
compound
benzyl
glutamyl
Prior art date
Application number
HK02104871.4A
Other languages
English (en)
Chinese (zh)
Other versions
HK1043310A1 (en
Inventor
托马斯‧雷得美尔
托馬斯‧雷得美爾
劳伦斯‧M‧卡瓦
罗伯特‧T‧卢穆
勞倫斯‧M‧卡瓦
马修‧H‧利特尔
罗伯特‧W‧马克撒塔
羅伯特‧T‧盧穆
史蒂文‧R‧修
胡果‧O‧维拉
馬修‧H‧利特爾
米歇尔‧R‧柯孜卢斯基
羅伯特‧W‧馬克撒塔
胡果‧O‧維拉
米歇爾‧R‧柯孜盧斯基
Original Assignee
泰立克公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 泰立克公司 filed Critical 泰立克公司
Publication of HK1043310A1 publication Critical patent/HK1043310A1/xx
Publication of HK1043310B publication Critical patent/HK1043310B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02104871.4A 1999-01-27 2000-01-27 含有谷胱甘肽类似物的治疗用组合物 HK1043310B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23853099A 1999-01-27 1999-01-27
US09/238,530 1999-01-27
PCT/US2000/002297 WO2000044366A2 (en) 1999-01-27 2000-01-27 Therapeutic compositions containing glutathione analogs

Publications (2)

Publication Number Publication Date
HK1043310A1 HK1043310A1 (en) 2002-09-13
HK1043310B true HK1043310B (zh) 2005-10-07

Family

ID=22898312

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104871.4A HK1043310B (zh) 1999-01-27 2000-01-27 含有谷胱甘肽类似物的治疗用组合物

Country Status (12)

Country Link
EP (1) EP1143992B1 (OSRAM)
JP (2) JP2002535359A (OSRAM)
KR (1) KR100750842B1 (OSRAM)
CN (1) CN1185008C (OSRAM)
AT (1) ATE286741T1 (OSRAM)
AU (1) AU778340B2 (OSRAM)
CA (1) CA2360795C (OSRAM)
DE (1) DE60017359T2 (OSRAM)
ES (1) ES2231159T3 (OSRAM)
HK (1) HK1043310B (OSRAM)
PT (1) PT1143992E (OSRAM)
WO (1) WO2000044366A2 (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69925824D1 (de) 1998-04-16 2005-07-21 Teijin Ltd Glutathionderivate und dazugehörige dosisformen
US7029695B2 (en) 2001-07-10 2006-04-18 Telik, Inc. Therapeutic compositions containing glutathione analogs
DE602006003064D1 (en) 2005-01-06 2008-11-20 Telik Inc Tripeptid- und tetrapeptid-thioether
CN101434645B (zh) * 2008-12-24 2013-01-16 中国农业大学 一种合成寡肽及其用途
JP2015500809A (ja) * 2011-12-02 2015-01-08 テリク， インコーポレイテッド 非晶質エザチオスタット非溶媒和物
CN108863888B (zh) * 2018-07-18 2021-10-12 吉尔生化（上海）有限公司 一种(s)-1-(叔丁氧羰基)-5-氧吡咯烷-2-羧酸乙酯的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786336A (en) * 1991-04-29 1998-07-28 Terrapin Technologies, Inc. Target-selective protocols based on mimics
JP3118869B2 (ja) * 1991-05-14 2000-12-18 ウェルファイド株式会社 プロスタグランジン類含有脂肪小体組成物
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
JP3383704B2 (ja) * 1993-04-02 2003-03-04 わかもと製薬株式会社 安定なリポソーム水分散液
EP0721328A4 (en) * 1993-09-27 1997-09-17 Smithkline Beecham Corp CAMPTOTHECIN FORMULATIONS
JP2891883B2 (ja) * 1993-11-05 1999-05-17 学校法人近畿大学 抗白内障医薬組成物
DK0831877T3 (da) * 1995-06-07 2005-02-14 Telik Inc Metabolske virkninger af visse glutathionanaloge

Also Published As

Publication number Publication date
ES2231159T3 (es) 2005-05-16
CA2360795C (en) 2010-03-23
AU778340B2 (en) 2004-12-02
WO2000044366A3 (en) 2000-12-21
CN1185008C (zh) 2005-01-19
HK1043310A1 (en) 2002-09-13
DE60017359T2 (de) 2005-12-01
JP2007326877A (ja) 2007-12-20
KR20010101775A (ko) 2001-11-14
JP2002535359A (ja) 2002-10-22
DE60017359D1 (de) 2005-02-17
EP1143992B1 (en) 2005-01-12
AU2976700A (en) 2000-08-18
WO2000044366A2 (en) 2000-08-03
EP1143992A2 (en) 2001-10-17
ATE286741T1 (de) 2005-01-15
PT1143992E (pt) 2005-05-31
CN1342084A (zh) 2002-03-27
CA2360795A1 (en) 2000-08-03
KR100750842B1 (ko) 2007-08-22

Similar Documents

Publication Publication Date Title
US7029695B2 (en) Therapeutic compositions containing glutathione analogs
JP3074733B2 (ja) 脂肪乳剤
RU2632433C2 (ru) Липидный преконцентрат с замедленным высвобождением фармакологически активного вещества и фармацевтическая композиция, содержащая его
FI86371C (fi) Foerfarande foer framstaellning av farmaceutiska liposomkompositioner.
HUT74423A (en) Pharmaceutical basic compositions
US5283067A (en) Parenteral suspensions
JP2009507049A (ja) リン脂質のポリエチレングリコール誘導体に包み込まれたビンカアルカロイド系制癌剤のナノミセル製剤
JP4059627B2 (ja) グルタチオン誘導体とその投与形態
US4983397A (en) Pharmaceutical compositions consisting of acylated phospholipids
WO2014141127A1 (en) Composition containing buffered aminoalkyl glucosaminide phosphate derivatives and its use for enhancing an immune response
JP2847783B2 (ja) 抗癌活性増強剤
KR102758330B1 (ko) 황화물을 포함하는 이온화 가능한 지질 및 이를 포함하는 지질나노입자
CN1055483A (zh) 肽药物的长效脂质体制剂及其制备
JP2007326877A (ja) グルタチオン類縁体を含有する治療用組成物
JPS6296431A (ja) 医薬組成物およびその調製に適した混合物
CN1739525A (zh) 一种新型的聚乙二醇衍生化磷脂包载前列腺素e1的纳米微粒给药系统
CN1700906A (zh) 稳定的无菌过滤性脂质体包封的紫杉烷和其他抗肿瘤药物
CN1164261C (zh) 6,9-二-[(2-氨基乙基)氨基]苯并[g]异喹啉-5,10-二酮二马来酸酯的脂质体制剂及其制备用途
KR101971451B1 (ko) ２―하이드록시올레산이 포함된 지질 비히클의 용도
CN1151797C (zh) 肿瘤-血管生成抑制剂和药学组合物
CN103275178B (zh) 正十二酸-rgd-正十四醇介导利尼法尼靶向脂质体的制备及抗肿瘤活性评价
CN1875946A (zh) 10－羟基喜树碱纳米粒及其制备方法
CN1413575A (zh) 可包覆高含量疏水性物质的脂质体
CN1743337A (zh) 一种紫杉醇衍生物及其药物组合物
JPH04169532A (ja) 脂溶性白金錯体含有リポソーム製剤

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130127